Cargando…
Osteonecrosis of the jaw in a Crohn’s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report
BACKGROUND: Bisphosphonates have a widespread indication for osteoporosis and are also applied in cancer patients with skeletal-related conditions. Bisphosphonate-associated osteonecrosis of the jaw (BRONJ) is a feared side effect which is hard to treat and often affects patient´s quality of life in...
Autores principales: | Preidl, Raimund HM, Ebker, Tobias, Raithel, Martin, Wehrhan, Falk, Neukam, Friedrich W, Stockmann, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890650/ https://www.ncbi.nlm.nih.gov/pubmed/24400722 http://dx.doi.org/10.1186/1471-230X-14-6 |
Ejemplares similares
-
Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: An immunohistological study
por: Stockmann, Philipp, et al.
Publicado: (2011) -
Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
por: Gross, Christian, et al.
Publicado: (2017) -
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
por: Wehrhan, Falk, et al.
Publicado: (2010) -
Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: A histological study on biopsies
por: Wehrhan, Falk, et al.
Publicado: (2011) -
Osteonecrosis of jaw associated with bisphosphonate use
por: Rastogi, Ashu, et al.
Publicado: (2012)